Figure 1 : Detection of anti-glutamic acid decarboxylase 65 (GAD65)
antibodies in type 1 diabetes patients.

(a) Age-wise detection of anti-GAD65 antibodies in type 1 diabetes (T1D) patients.
*p<0.001 versus anti-GAD65 antibodies detected in T1D patients of age>35;
*p<0.0001 versus anti-GAD65 antibodies detected in normal human subjects (NHS).
(b) Glycosylated hemoglobin (HbA1C)-wise detection of anti-GAD65 antibodies in
T1D patients. #p<0.001 versus anti-GAD65 antibodies detected in T1D patients with
HbA1C>7.2; #p<0.0001 versus anti-GAD65 antibodies detected in NHS. The number
of T1D serum samples was 57 and NHS was 42. GAD65-specific sandwich ELISAs were
used and serum samples were 1:100 diluted. Results show mean with 95% CI.

Rasheed et al.Journal of Diabetes Research and Clinical Metabolism  2013 2:24DOI : 10.7243/2050-0866-2-24